Therapy with orally administered methoxsalen and ultraviolet A radiation during childhood increases the risk of basal cell carcinoma. The PUVA Follow-up Study.

Published

Journal Article (Review)

A child was treated from age 18 months to 8 years with oral methoxsalen and ultraviolet A radiation (PUVA) for refractory psoriasis. Two basal cell cancers developed before age 21 years, suggesting that exposure to PUVA in childhood increases the risk of basal cell cancer.

Full Text

Duke Authors

Cited Authors

  • Stern, RS; Nichols, KT

Published Date

  • December 1996

Published In

Volume / Issue

  • 129 / 6

Start / End Page

  • 915 - 917

PubMed ID

  • 8969737

Pubmed Central ID

  • 8969737

International Standard Serial Number (ISSN)

  • 0022-3476

Digital Object Identifier (DOI)

  • 10.1016/s0022-3476(96)70039-2

Language

  • eng

Conference Location

  • United States